American Century Companies
TNYA icon

American Century Companies’s Tenaya Therapeutics TNYA Stock Holding History

American Century Companies’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-126,008
Closed -$180K – 2957
2024
Q4 		$180K Buy
126,008
+5,999
+5% +$13.4K ﹤0.01% 2797
2024
Q3 		$232K Buy
120,009
+17,895
+18% +$50.5K ﹤0.01% 2729
2024
Q2 		$317K Buy
102,114
+22,146
+28% +$91.5K ﹤0.01% 2607
2024
Q1 		$418K Buy
79,968
+37,920
+90% +$181K ﹤0.01% 2513
2023
Q4 		$136K Buy
42,048
+6,054
+17% +$13.1K ﹤0.01% 2766
2023
Q3 		$91.8K Buy
35,994
+15,117
+72% +$63.3K ﹤0.01% 2729
2023
Q2 		$123K Buy
+20,877
New +$121K ﹤0.01% 2646

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies's TNYA Position: Q1 2025 in Review

American Century Companies sold out of Tenaya Therapeutics (TNYA) in Q1 2025, closing a stake of 126,008 shares — an estimated $180K sold.

American Century Companies first reported a position in TNYA in Q2 2023 and held it in 7 quarters. The position peaked at $418K in Q1 2024. 107 funds tracked by Wall St. Rank hold TNYA as of Q1 2025.

  • American Century Companies reported no remaining Tenaya Therapeutics position as of Q1 2025 after selling out during the quarter.
  • American Century Companies sold 126,008 Tenaya Therapeutics shares in Q1 2025, an estimated $180K.
  • American Century Companies first reported a position in Tenaya Therapeutics in Q2 2023 and held it in 7 quarters.
  • American Century Companies's Tenaya Therapeutics position peaked at $418K in Q1 2024.
  • 107 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2025.

Based on American Century Companies's 13F filing for Q1 2025, filed 13 May 2025.